FDA Office of Generic Drugs
Executive Summary
Acting Deputy Director Robert Pollock leaving the agency Jan. 1 to work for Lachman Consulting Services. He is retiring from the Public Health Service with the rank of captain after 20 years in the Commissioned Corps. In recognition of his service, he has received 10 PHS awards. Since joining FDA in 1985, Pollock has held numerous positions of increasing responsibility in the division/office of generic drugs: consumer safety officer; deputy chief and chief, Review Support Branch; chief, Program Support Staff; and director, Division of Labeling and Program Support. Prior to joining FDA, Pollock was at the Health Resources & Services Administration